Visit the WIS FDA Info.com for the best regulatory news and information

Many of our recently held briefings are available on audiocassette files. Visit our Tapes Library for our highly regarded series on:

  21 CFR Part 11
  Adverse Event
Reporting
  Branded/Generic
Drug Policy
  Clinical Research
  Computer Validation 
  FDA Enforcement
  Human Research Protections
  Prescription Drug Marketing
  Order Form


Tapes Library

Prescription Drug Marketing: Combination Product Development
Speakers:
David L. West, Ph.D. Vice President, Medical Devices, Quintiles Consulting
Chris Sloan, Senior Consultant, Quintiles Consulting
Date of Briefing:
January 26, 2005
Approximate length:
One hour
Description:
Learn first-hand from industry professionals on how to address business factors as well as regulatory and technical development factors that can influence a company’s approach to product development and to traversing the regulatory pathway.
Price:
$225 CD
ttttttttttttt

Go to the Order Form

Click here to see briefings from 2002.


Tapes Library

Prescription Drug Marketing: Designing a Cost-Effective and Streamlined Cold Chain Process
Speaker:
Raymond Jenkins, Demand and Logistics Manager, Mayne Pharma
Date of Briefing:
November 15, 2004
Approximate length:
One hour
Description:
In the world of Cold Chain Distribution, time is money. Getting your product from production to market is critical to your company’s success – Learn best practices from a cold chain expert.
Price:
$225 Tape
ttttttttttttt

Go to the Order Form


Tapes Library

Prescription Drug Marketing: Auditing and Evaluation of Company Process and Procedures
Speaker:
Steven Goldman, MD, Steven A. Goldman Consulting Services
Date of Briefing:
October 13, 2004
Approximate length:
One hour
Description:
In this presentation, Stephen A. Goldman, M.D., Managing Member of Stephen A. Goldman Consulting Services, L.L.C. – and former Medical Director, MedWatch, FDA – will review the details of FDA postmarketing inspections, including in-depth discussion of Standard Operating Procedures and “lessons learned” from performing audits of company clinical safety and pharmacovigilance programs both inside and outside the U.S.
Price:
$195 Tape
ptovvvvv
Go to the Order Form



Tapes Library
Prescription Drug Marketing: Integrating Risk Management into Quality Systems
Speaker:
Christine Driscoll, Director of the Global Quality Systems Program, Abbott Laboratories
Date of Briefing:
April 29, 2004
Approximate length:
One hour
Description:

This briefing will review key risk related issues – both pre- and post-marketing – revealing common emerging trends and different directions taken by the pharmaceutical industry. Our presenter, Christine Driscoll, Director of the Global Quality Systems Program for Abbott Laboratories, will explain how related industries utilize risk management principles, how these principles are influencing the pharmaceutical industry, and how they apply to your operation.

Price:
$195 Tape
rrrrrrrrrrr
Go to the Order Form

Archive Library

Prescription Drug Marketing: Rx Re-Importation & Medicare Reform
Speaker:
Sally C. Pipes, President and CEO, Pacific Research Institute
Date of Briefing:
February 12, 2004
Approximate length:
One hour
Description:
American access to prescription drugs imported from Canada could become the hottest public policy issue this year. There are a number of concerns associated with re-importing Canadian drugs such as safety, increased black market activity, liability, and perhaps the most overlooked thus far -- economic impact on U.S. citizens and prescription drug manufacturers by Canadian price controls. Addressing these issues will be Sally C. Pipes, President/CEO of Pacific Research Institute.
Price:
$195 Tape
ttttttttttttt
Go to the Order Form

Archive Library

Prescription Drug Marketing: Outcome Analysis for Regulatory Impact Assessment
Speaker:
Dr. Eleanor Perfetto, President, Drug Information Association
Date of Briefing:
September 22, 2003
Approximate length:
One hour
Description:
Our presenter, Dr. Eleanor Perfetto, the current president of the Drug Information Assn. and who has pioneered the use of OA on regulatory impact analysis -- will explain how you can use her firm’s strategies/techniques to assess the impact of regulations on your operations, suppliers, and customers.
Price:
$195 Tape
ptovvvvv
Go to the Order Form



 

Page last updated October 16, 2006

Washington Information Source © Copyright 2006

208 South King Street, Leesburg, VA 20175
Tel: (703) 779-8777 . Fax: (703) 779-2508
service@fdainfo.com
. www.fdainfo.com/expertbriefings/

This site has been accessed: times.